These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 31735780)
1. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation. Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780 [TBL] [Abstract][Full Text] [Related]
2. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593 [TBL] [Abstract][Full Text] [Related]
3. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation. Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation. Vlachos K; Efremidis M; Bazoukis G; Letsas KP; Saplaouras A; Georgopoulos S; Karamichalakis N; Rokiza A; Sakellaropoulou A; Kolokathis AM; Efremidis T; Asvestas D; Sideris A Clin Cardiol; 2017 Oct; 40(10):847-852. PubMed ID: 28561951 [TBL] [Abstract][Full Text] [Related]
5. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events. Nakamura K; Naito S; Sasaki T; Take Y; Minami K; Kitagawa Y; Motoda H; Inoue M; Otsuka Y; Niijima K; Yamashita E; Sugai Y; Kumagai K; Koyama K; Funabashi N; Oshima S Europace; 2019 Feb; 21(2):259-267. PubMed ID: 29982562 [TBL] [Abstract][Full Text] [Related]
6. Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation. Nakamura R; Okishige K; Shigeta T; Nishimura T; Kurabayashi M; Yamauchi Y; Sasano T; Hirao K J Cardiol; 2019 Aug; 74(2):150-155. PubMed ID: 31029455 [TBL] [Abstract][Full Text] [Related]
7. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants. Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158 [TBL] [Abstract][Full Text] [Related]